Stratos Wealth Partners LTD. Buys Shares of 25,000 Myomo, Inc. (NYSEAMERICAN:MYO)

Stratos Wealth Partners LTD. acquired a new stake in shares of Myomo, Inc. (NYSEAMERICAN:MYO) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 25,000 shares of the company’s stock, valued at approximately $125,000.

Other hedge funds also recently modified their holdings of the company. Worth Venture Partners LLC boosted its holdings in shares of Myomo by 24.9% during the 3rd quarter. Worth Venture Partners LLC now owns 1,397,861 shares of the company’s stock valued at $1,552,000 after acquiring an additional 278,544 shares in the last quarter. AIGH Capital Management LLC raised its position in Myomo by 9.4% during the 3rd quarter. AIGH Capital Management LLC now owns 2,188,883 shares of the company’s stock worth $2,430,000 after purchasing an additional 188,883 shares during the last quarter. PFG Advisors bought a new position in Myomo during the 4th quarter worth $134,000. Essex Investment Management Co. LLC bought a new position in Myomo during the 3rd quarter worth $325,000. Finally, Accurate Wealth Management LLC raised its position in Myomo by 21.8% during the 4th quarter. Accurate Wealth Management LLC now owns 21,565 shares of the company’s stock worth $108,000 after purchasing an additional 3,864 shares during the last quarter. Institutional investors and hedge funds own 44.99% of the company’s stock.

Insider Buying and Selling

In other Myomo news, Director Thomas F. Kirk acquired 50,000 shares of the stock in a transaction dated Thursday, March 14th. The stock was purchased at an average cost of $3.50 per share, with a total value of $175,000.00. Following the transaction, the director now owns 186,499 shares in the company, valued at approximately $652,746.50. The acquisition was disclosed in a filing with the SEC, which is available at this link. 3.20% of the stock is owned by corporate insiders.

Myomo Price Performance

Shares of NYSEAMERICAN:MYO opened at $2.78 on Thursday. The firm has a market cap of $79.20 million, a P/E ratio of -9.93 and a beta of 1.52. Myomo, Inc. has a 12-month low of $0.37 and a 12-month high of $5.58.

Myomo (NYSEAMERICAN:MYO) last announced its earnings results on Thursday, March 7th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.02). The company had revenue of $4.76 million for the quarter, compared to the consensus estimate of $4.70 million. Myomo had a negative return on equity of 84.72% and a negative net margin of 42.34%. Analysts expect that Myomo, Inc. will post -0.18 earnings per share for the current fiscal year.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.